Susquehanna International Group, LLP Red Hill Biopharma Ltd. Call Options Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$0.14 - $695.9 $1,148 - $5.71 Million	8,200 Added 38.86%	29,300 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.5 - $523.8 $2,600 - $2.72 Million	-5,200 Reduced 19.77%	21,100 $11,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.58 $24,255 - $99,330	-38,500 Reduced 59.41%	26,300 $23,000
Q1 2022 May 16, 2022	SELL	$1.65 - $3.12 $287,100 - $542,880	-174,000 Reduced 72.86%	64,800 $163,000
Q4 2021 Feb 14, 2022	SELL	$2.31 - $5.85 $302,841 - $766,935	-131,100 Reduced 35.44%	238,800 $616,000
Q3 2021 Nov 15, 2021	BUY	$4.55 - $10.36 $88,725 - $202,020	19,500 Added 5.57%	369,900 $1.69 Million
Q2 2021 Aug 11, 2021	BUY	$5.98 - $7.51 $468,234 - $588,033	78,300 Added 28.78%	350,400 $2.41 Million
Q1 2021 May 17, 2021	BUY	$6.98 - $11.29 $1.32 Million - $2.14 Million	189,200 Added 228.23%	272,100 $1.99 Million
Q4 2020 Feb 16, 2021	SELL	$7.81 - $10.39 $600,589 - $798,991	-76,900 Reduced 48.12%	82,900 $670,000
Q3 2020 Nov 16, 2020	BUY	$6.34 - $10.83 $447,604 - $764,598	70,600 Added 79.15%	159,800 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$4.6 - $8.6 $359,260 - $671,660	78,100 Added 703.6%	89,200 $598,000
Q2 2019 Aug 14, 2019	SELL	$6.34 - $8.8 $23,458 - $32,560	-3,700 Reduced 25.0%	11,100 $72,000
Q1 2019 May 15, 2019	BUY	$6.06 - $9.0 $13,332 - $19,800	2,200 Added 17.46%	14,800 $123,000
Q4 2018 Feb 14, 2019	SELL	$5.18 - $9.35 $19,166 - $34,595	-3,700 Reduced 22.7%	12,600 $70,000
Q3 2018 Nov 14, 2018	SELL	$6.0 - $11.35 $10,800 - $20,430	-1,800 Reduced 9.94%	16,300 $144,000
Q2 2018 Aug 14, 2018	BUY	$4.82 - $8.53 $87,242 - $154,393	18,100 New	18,100 $154,000

Others Institutions Holding RDHL

# of Institutions

Shares Held

40.4K

Call Options Held

Put Options Held

Eaton Vance Management Boston, MA

40.4K
Shares

$352,840
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About RedHill Biopharma Ltd.

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $557M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

More about RDHL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account